Narayana Hrudayalaya Limited Stock

Equities

NH

INE410P01011

Healthcare Facilities & Services

Delayed NSE India S.E. 03:01:40 2024-04-25 am EDT 5-day change 1st Jan Change
1,274 INR +0.92% Intraday chart for Narayana Hrudayalaya Limited +2.83% +5.95%
Sales 2024 * 50.99B 612M Sales 2025 * 57.95B 695M Capitalization 256B 3.08B
Net income 2024 * 8.09B 97.06M Net income 2025 * 8.37B 100M EV / Sales 2024 * 5.1 x
Net Debt 2024 * 3.63B 43.61M Net Debt 2025 * 5.37B 64.48M EV / Sales 2025 * 4.52 x
P/E ratio 2024 *
31.8 x
P/E ratio 2025 *
30.4 x
Employees 11,923
Yield 2024 *
0.15%
Yield 2025 *
0.15%
Free-Float 33.02%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.86%
1 week+2.83%
Current month-0.80%
1 month+1.75%
3 months+0.94%
6 months+26.18%
Current year+5.95%
More quotes
1 week
1 211.35
Extreme 1211.35
1 285.85
1 month
1 211.35
Extreme 1211.35
1 375.00
Current year
1 147.05
Extreme 1147.05
1 444.90
1 year
748.90
Extreme 748.9
1 444.90
3 years
393.05
Extreme 393.05
1 444.90
5 years
184.30
Extreme 184.3
1 444.90
10 years
182.80
Extreme 182.8
1 444.90
More quotes
Managers TitleAgeSince
Chief Executive Officer - 19-02-02
Director of Finance/CFO - 21-12-07
Chief Operating Officer - 01-07-31
Members of the board TitleAgeSince
Director/Board Member 71 -
Founder 70 00-07-18
Director/Board Member 47 23-03-28
More insiders
Date Price Change Volume
24-04-25 1,274 +0.92% 78 895
24-04-24 1,263 +0.90% 176,087
24-04-23 1,251 -0.34% 273,737
24-04-22 1,256 +1.05% 242,623
24-04-19 1,242 +0.32% 174,736

Delayed Quote NSE India S.E., April 25, 2024 at 03:01 am EDT

More quotes
Narayana Hrudayalaya Limited is an India-based healthcare service provider, operating a chain of multispecialty, tertiary, and primary healthcare facilities. The Company is primarily engaged in the business of rendering medical and healthcare services. It has a network of multispecialty and super specialty hospitals spread across multiple locations. The Company owns and operates certain hospitals. Its medical services include anesthesia, blood bank, bone marrow transplant (stem cell transplant), breast cancer, electrophysiology, emergency medicine, endocrinology, family medicine, gastrointestinal oncology, general surgery, geriatrics, gynecology - oncology, pulmonology, radiation oncology, hematology, heart transplant, hepatology liver transplantation and infectious diseases. The Company has a network of approximately 19 hospitals and three heart centers across India along with overseas presence at Cayman Islands, with over 5,860 operational beds and a capacity of over 6,160 beds.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
1,263 INR
Average target price
1,422 INR
Spread / Average Target
+12.60%
Consensus